Search

Stephan B Abramson

from Vancouver, WA
Age ~79
Get Report
Also known as:
Stephan Barry Abramson, Stephan Kathleen Abramson, Abramson Abramson
Related to:
Peyton K Taylor, 32Kathleen M Abramson, 76
Connected to:
Adam M Abramson, 46Alison J Abramson, 50Ami N Abramson, 49Andrew G Abramson, 52Fara B Abramson, 56Igor Abramson, 34Isabelle Abramson, 73Issiah D Abramson, 44Jeffrey Abramson, 78Joseph G Abramson, 59

Stephan Abramson Phones & Addresses

  • Vancouver, WA
  • 2358 Highland Ave, Altadena, CA 91001 (626) 794-3235 (626) 794-6671
  • Los Angeles, CA
  • Redlands, CA
  • 4211 NE 131St St, Vancouver, WA 98686

Education

Degree: Graduate or professional degree

Resumes

Resumes

Stephan Abramson Photo 1

Owner, Lifesci Partners, Llc

View page
Position:
Owner at LifeSci Partners, LLC
Location:
Portland, Oregon Area
Industry:
Biotechnology
Work:
LifeSci Partners, LLC since Jan 2003
Owner
Alpha Therapeutic Corporation 1998 - 2003
Director, Clinical Development; Director, Business Development
Alpha Therapeutic Corporation 1986 - 2003
Director, Business & Clinical Development
Education:
Harvard University 1967 - 1975
Doctor of Philosophy (PhD), Biochemistry California Institute of Technology 1963 - 1967
Bachelor of Science (BSc), Chemistry
Stephan Abramson Photo 2

Stephan Abramson

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mr. Stephan Abramson
Owner
Lifesci Partners Llc
Management Consultants
4211 NE 131St St, Vancouver, WA 98686
(360) 574-3363
Stephan Abramson
Owner
Lifesci Partners Llc
Biomedical Consulting · Pharmacy
4211 NE 131 St, Vancouver, WA 98686
Vancouver, WA 98686
(360) 574-3363

Publications

Us Patents

Microdispersion Treatment Of A Protein Or Pharmaceutical

View page
US Patent:
20030161756, Aug 28, 2003
Filed:
Feb 22, 2002
Appl. No.:
10/080836
Inventors:
Charles Heldebrant - Arcadia CA, US
Stephan Abramson - Altadena CA, US
International Classification:
A61L002/08
US Classification:
422/022000, 422/024000, 261/115000, 250/435000
Abstract:
A device and method for non-destructively inactivating microorganisms, and more particularly for non-destructively inactivating microorganisms by subjecting a microdispersion of biological or other pharmaceutical material to short-duration, high-intensity pulses of an energetic emission is provided. The microdispersion treatment device comprises an emitter; a power supply coupled to the emitter; a flow chamber designed to produce a microdispersion of the material across an exposure region such that the material is substantially non-destructively exposed to an emission emitted from the emitter.
Control profile
Stephan B Abramson from Vancouver, WA, age ~79 Get Report